JP2016514686A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016514686A5 JP2016514686A5 JP2016503003A JP2016503003A JP2016514686A5 JP 2016514686 A5 JP2016514686 A5 JP 2016514686A5 JP 2016503003 A JP2016503003 A JP 2016503003A JP 2016503003 A JP2016503003 A JP 2016503003A JP 2016514686 A5 JP2016514686 A5 JP 2016514686A5
- Authority
- JP
- Japan
- Prior art keywords
- weight
- matrix
- dosage form
- wax
- particles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002552 dosage form Substances 0.000 claims 45
- 239000011159 matrix material Substances 0.000 claims 45
- 239000002245 particle Substances 0.000 claims 42
- 239000001993 wax Substances 0.000 claims 32
- KJADKKWYZYXHBB-XBWDGYHZSA-N Topiramic acid Chemical compound C1O[C@@]2(COS(N)(=O)=O)OC(C)(C)O[C@H]2[C@@H]2OC(C)(C)O[C@@H]21 KJADKKWYZYXHBB-XBWDGYHZSA-N 0.000 claims 24
- 229960004394 topiramate Drugs 0.000 claims 24
- 239000011230 binding agent Substances 0.000 claims 20
- 239000004094 surface-active agent Substances 0.000 claims 18
- 229920001577 copolymer Polymers 0.000 claims 12
- 239000007788 liquid Substances 0.000 claims 9
- 239000007884 disintegrant Substances 0.000 claims 7
- 239000000843 powder Substances 0.000 claims 7
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims 6
- 235000003599 food sweetener Nutrition 0.000 claims 6
- 229920000642 polymer Polymers 0.000 claims 6
- 239000003765 sweetening agent Substances 0.000 claims 6
- 239000011248 coating agent Substances 0.000 claims 5
- 238000000576 coating method Methods 0.000 claims 5
- 238000007639 printing Methods 0.000 claims 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims 4
- 229940075614 colloidal silicon dioxide Drugs 0.000 claims 4
- 239000000203 mixture Substances 0.000 claims 4
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 claims 3
- 239000012530 fluid Substances 0.000 claims 3
- 229920000831 ionic polymer Polymers 0.000 claims 3
- 239000000463 material Substances 0.000 claims 3
- 229920000058 polyacrylate Polymers 0.000 claims 3
- 238000010146 3D printing Methods 0.000 claims 2
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 235000011187 glycerol Nutrition 0.000 claims 2
- 239000007787 solid Substances 0.000 claims 2
- 239000007921 spray Substances 0.000 claims 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 1
- 229930195725 Mannitol Natural products 0.000 claims 1
- 229960000913 crospovidone Drugs 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 235000012489 doughnuts Nutrition 0.000 claims 1
- 235000010355 mannitol Nutrition 0.000 claims 1
- 239000000594 mannitol Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 claims 1
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 claims 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims 1
- 239000000377 silicon dioxide Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361791592P | 2013-03-15 | 2013-03-15 | |
| US61/791,592 | 2013-03-15 | ||
| PCT/US2014/029168 WO2014144661A1 (en) | 2013-03-15 | 2014-03-14 | Rapidly dispersible dosage form of topiramate |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016514686A JP2016514686A (ja) | 2016-05-23 |
| JP2016514686A5 true JP2016514686A5 (enExample) | 2017-04-06 |
| JP6466399B2 JP6466399B2 (ja) | 2019-02-06 |
Family
ID=51537752
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016503003A Active JP6466399B2 (ja) | 2013-03-15 | 2014-03-14 | トピラマートの急速分散性の剤形 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US9492380B2 (enExample) |
| EP (1) | EP2968181B1 (enExample) |
| JP (1) | JP6466399B2 (enExample) |
| CN (1) | CN105050588B (enExample) |
| AU (2) | AU2014228861B2 (enExample) |
| CA (1) | CA2906172C (enExample) |
| ES (1) | ES2761407T3 (enExample) |
| HK (1) | HK1213473A1 (enExample) |
| MX (1) | MX365914B (enExample) |
| WO (1) | WO2014144661A1 (enExample) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2923102C (en) * | 2007-08-13 | 2019-10-15 | Omeho Life Sciences Inc. | Abuse resistant drugs, method of use and method of making |
| US9339489B2 (en) | 2013-03-15 | 2016-05-17 | Aprecia Pharmaceuticals Company | Rapid disperse dosage form containing levetiracetam |
| AU2014228990B2 (en) | 2013-03-15 | 2017-02-02 | Aprecia Pharmaceuticals LLC | Rapid disperse dosage form containing levetiracetam |
| CN104586871B (zh) * | 2014-12-27 | 2018-01-16 | 北京罗诺强施医药技术研发中心有限公司 | 包含托吡酯的药物组合物 |
| US20160243036A1 (en) * | 2015-02-25 | 2016-08-25 | Intelgenx Corp. | Film dosage forms containing amorphous active agents |
| EP4512394A3 (en) | 2015-06-03 | 2025-10-22 | Triastek, Inc. | Dosage forms and use thereof |
| EP3441065B1 (en) * | 2016-04-06 | 2024-10-09 | Astellas Pharma Inc. | Fast-eluting three-dimensional molding, filament for fast-eluting three-dimensional molding, and material for fast-eluting three-dimensional molding |
| RU2722385C1 (ru) | 2016-09-02 | 2020-05-29 | Ново Футура ИВС | Одноразовый гриль и способ изготовления одноразового гриля |
| CA3051614A1 (en) | 2017-01-26 | 2018-08-02 | Triastek, Inc. | Dosage forms of controlled release at specific gastrointestinal sites |
| CN107213126B (zh) * | 2017-05-17 | 2020-06-23 | 西安棣加生物科技有限公司 | 一种3d打印技术制备治疗高磷血症的口腔速崩片的方法 |
| CN107252418B (zh) * | 2017-05-17 | 2020-06-23 | 西安棣加生物科技有限公司 | 一种3d打印技术制备治疗低钾血症的口腔速崩片的方法 |
| US10703549B2 (en) * | 2017-06-30 | 2020-07-07 | The Procter And Gamble Company | Water soluble containers and methods of making them |
| MX2020004403A (es) * | 2017-11-02 | 2020-08-06 | Zambon Spa | Composiciones farmaceuticas que comprenden safinamida. |
| JP7360949B2 (ja) * | 2017-12-26 | 2023-10-13 | 東和薬品株式会社 | 環状口腔内崩壊錠 |
| US11571391B2 (en) | 2018-01-09 | 2023-02-07 | Triastek, Inc. | Oral drug dosage forms compromising a fixed-dose of an ADHD non-stimulant and an ADHD stimulant |
| US12544446B2 (en) | 2018-03-02 | 2026-02-10 | Vitiprints, LLC | Printed delivery device having supplements |
| CA3096124A1 (en) | 2018-04-10 | 2019-10-17 | Panacea Biomatx, Inc. | Method and system for making personalized nutritional and pharmaceutical formulations using additive manufacturing |
| AU2019337800A1 (en) * | 2018-09-14 | 2021-05-13 | Merck Patent Gmbh | Process for the preparation of a coated solid pharmaceutical dosage form |
| EP3866757B1 (en) | 2018-10-15 | 2022-08-10 | Aprecia Pharmaceuticals LLC | Method and system for forming a dosage form within a packaging |
| WO2020104837A1 (en) | 2018-11-21 | 2020-05-28 | Rosemont Pharmaceuticals Limited | Oral topiramate suspension formulations with extended shelf stability and enhanced bioavailability |
| TWI849062B (zh) | 2019-02-22 | 2024-07-21 | 英商康泰倫特英國斯文敦載迪斯有限公司 | 保存水性懸浮液中以無溶劑混合方法製備的功能性塗覆之活性醫藥成份微粒 |
| CN113507923B (zh) | 2019-02-22 | 2024-03-26 | 康特伦英国斯温顿捷迪斯有限公司 | 在线混合期间混悬液的曝气最小化 |
| GB2585413B (en) | 2019-02-22 | 2023-04-26 | Catalent Uk Swindon Zydis Ltd | Minimizing agglomeration of drug particle coating material during storage to stabilize disintegration times of pharmaceutical products |
| WO2020169989A1 (en) | 2019-02-22 | 2020-08-27 | Catalent U.K. Swindon Zydis Limited | Minimizing agglomeration, aeration, and preserving the coating of pharmaceutical compositions comprising ibuprofen |
| TWI883039B (zh) * | 2019-09-13 | 2025-05-11 | 日商明治股份有限公司 | 固形食品及固形乳 |
| AU2021296908A1 (en) | 2020-06-26 | 2023-02-16 | Aprecia Pharmaceuticals LLC | Rapidly-orodispersible tablets having an interior cavity |
| BR112023001716A2 (pt) * | 2020-07-31 | 2023-04-04 | Catalent Uk Swindon Zydis Ltd | Composições farmacêuticas compreendendo api revestido |
| KR20250008880A (ko) | 2022-04-13 | 2025-01-16 | 아프레시아 파마슈티칼즈 엘엘씨 | 전방향 자기 운동 장치를 이용한 적층 제조를 위한 시스템 및 방법 |
| WO2024108082A1 (en) | 2022-11-18 | 2024-05-23 | Aprecia Pharmaceuticals LLC | Orodispersive dosage forms containing droxidopa |
| GB2643925A (en) * | 2024-09-09 | 2026-03-11 | Novumgen Ltd | An orodispersible tablet of topiramate and its process of preparation |
Family Cites Families (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1548022A (en) | 1976-10-06 | 1979-07-04 | Wyeth John & Brother Ltd | Pharmaceutial dosage forms |
| US4513006A (en) | 1983-09-26 | 1985-04-23 | Mcneil Lab., Inc. | Anticonvulsant sulfamate derivatives |
| US4642903A (en) | 1985-03-26 | 1987-02-17 | R. P. Scherer Corporation | Freeze-dried foam dosage form |
| US4855326A (en) | 1987-04-20 | 1989-08-08 | Fuisz Pharmaceutical Ltd. | Rapidly dissoluble medicinal dosage unit and method of manufacture |
| EP0418596A3 (en) | 1989-09-21 | 1991-10-23 | American Cyanamid Company | Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form |
| US5178878A (en) | 1989-10-02 | 1993-01-12 | Cima Labs, Inc. | Effervescent dosage form with microparticles |
| US5578322A (en) | 1990-11-30 | 1996-11-26 | Yamanouchi Pharmaceutical Co., Ltd. | Quick release coated preparation |
| DE4200821A1 (de) | 1992-01-15 | 1993-07-22 | Bayer Ag | Geschmacksmaskierte pharmazeutische mittel |
| US5518730A (en) | 1992-06-03 | 1996-05-21 | Fuisz Technologies Ltd. | Biodegradable controlled release flash flow melt-spun delivery system |
| US5380473A (en) | 1992-10-23 | 1995-01-10 | Fuisz Technologies Ltd. | Process for making shearform matrix |
| WO1995001782A2 (en) | 1993-07-09 | 1995-01-19 | R.P. Scherer Corporation | Method for making freeze dried drug dosage forms |
| US5490962A (en) * | 1993-10-18 | 1996-02-13 | Massachusetts Institute Of Technology | Preparation of medical devices by solid free-form fabrication methods |
| US5738875A (en) | 1994-10-28 | 1998-04-14 | R.P. Scherer Corporation | Process for preparing solid pharmaceutical dosage forms |
| US5607697A (en) | 1995-06-07 | 1997-03-04 | Cima Labs, Incorporated | Taste masking microparticles for oral dosage forms |
| WO1998036738A1 (en) * | 1997-02-20 | 1998-08-27 | Therics, Inc. | Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same |
| FR2766089B1 (fr) | 1997-07-21 | 2000-06-02 | Prographarm Lab | Comprime multiparticulaire perfectionne a delitement rapide |
| UA65607C2 (uk) * | 1998-03-04 | 2004-04-15 | Орто-Макнейл Фармацевтикал, Інк. | Фармацевтична композиція (варіанти) та спосіб її приготування |
| EP1194153B1 (en) | 1999-07-09 | 2004-05-06 | Ortho-McNeil Pharmaceutical, Inc. | Taste masked pharmaceutical liquid formulations |
| WO2001010405A1 (en) * | 1999-08-04 | 2001-02-15 | Ranbaxy Laboratories Limited | Hydrodynamically balanced oral drug delivery system |
| DE19940944B4 (de) | 1999-08-31 | 2006-10-12 | Grünenthal GmbH | Retardierte, orale, pharmazeutische Darreichungsformen |
| AU2001263506A1 (en) * | 2000-05-18 | 2001-11-26 | Massachusetts Institute Of Technology | Encapsulating a toxic core within a non-toxic region in an oral dosage form |
| CA2440069A1 (en) | 2001-03-05 | 2002-09-12 | Ortho-Mcneil Pharmaceutical, Inc. | Taste masked pharmaceutical compositions |
| CA2464478C (en) * | 2001-10-29 | 2012-03-20 | Therics, Inc. | A system and method for uniaxial compression of an article, such as a three-dimensionally printed dosage form |
| US20030099708A1 (en) * | 2001-10-29 | 2003-05-29 | Therics, Inc | Printing or dispensing a suspension such as three-dimensional printing of dosage forms |
| AU2002302890A1 (en) * | 2002-02-04 | 2003-12-02 | Ranbaxy Laboratories Limited | Hydrodynamically balancing oral drug delivery system with biphasic release |
| FR2838647B1 (fr) | 2002-04-23 | 2006-02-17 | Particules enrobees a liberation prolongee, leur procede de preparation et comprimes les contenant | |
| CN1688292A (zh) * | 2002-09-04 | 2005-10-26 | 兰贝克赛实验室有限公司 | 掩味剂型及其制造方法 |
| AU2003302881A1 (en) | 2002-12-11 | 2004-06-30 | Ranbaxy Laboratories Limited | Coating composition for taste masking coating and methods for their application and use |
| CN1819819B (zh) | 2003-05-07 | 2011-03-09 | 株式会社三养社 | 用于制备速熔片的高度可塑性颗粒 |
| FR2858556B1 (fr) | 2003-08-06 | 2006-03-10 | Galenix Innovations | Composition pharmaceutique solide dispersible et/ou orodispersible non pelliculee contenant au moins le principe actif metformine, et procede de preparation |
| US20070154550A1 (en) | 2003-08-28 | 2007-07-05 | Potdar Arti | Pharmaceutical composition comprising anticonvulsant with taste mask coating |
| MXPA06007511A (es) * | 2003-12-29 | 2009-06-10 | Johnson & Johnson | Revestimientos de granulos de farmaco que imparten resistencia a la embarradura durante la compresion mecanica. |
| JP2008507508A (ja) * | 2004-07-22 | 2008-03-13 | 株式會社アモーレパシフィック | トピラメート徐放性製剤及びその製造方法 |
| US20060127479A1 (en) | 2004-10-08 | 2006-06-15 | Natrajan Kumaraperumal | Solvent free taste masked pharmaceutical compositions |
| US20060182796A1 (en) | 2005-02-03 | 2006-08-17 | Abrika Pharmaceuticals, Inc. | Taste masked pharmaceutical compositions |
| US20070092553A1 (en) | 2005-10-21 | 2007-04-26 | Pfab Lp | Compositions and methods of making rapidly dissolving lonically masked formulations |
| US9744137B2 (en) * | 2006-08-31 | 2017-08-29 | Supernus Pharmaceuticals, Inc. | Topiramate compositions and methods of enhancing its bioavailability |
| CN102114002B (zh) * | 2006-12-04 | 2016-05-11 | 苏佩努斯制药公司 | 托吡酯的增强的立即释放制剂 |
| KR101560176B1 (ko) * | 2007-10-31 | 2015-10-14 | 맥네일-피피씨, 인코포레이티드 | 구강내 붕해성 투여 형태 |
| WO2009106824A2 (en) * | 2008-02-25 | 2009-09-03 | Cipla Limited | Pharmaceutical formulations |
| ES2758624T3 (es) | 2009-02-12 | 2020-05-06 | Fuji Chem Ind Co Ltd | Composición de partículas desintegrantes y material de desintegración rápida moldeado por compresión que comprende la misma |
| US20100285130A1 (en) | 2009-05-06 | 2010-11-11 | Monosol Rx, Llc | Coating of complexed actives in film formulations |
| CN102802614A (zh) | 2009-06-04 | 2012-11-28 | 巴斯夫欧洲公司 | 含有被遮味活性成分的口腔崩解剂型 |
| CA2771358A1 (en) * | 2009-08-19 | 2011-02-24 | Sascha General | Drug delivery systems (wafer) for pediatric use |
| AR079862A1 (es) * | 2010-01-08 | 2012-02-22 | Eurand Inc | Composicion de topiramato con sabor enmascarado, un comprimido desintegrable oralmente que comprende la misma y metodo de preparacion |
| JP6133009B2 (ja) * | 2010-08-11 | 2017-05-24 | 協和発酵キリン株式会社 | トピラマート顆粒 |
| US9381154B2 (en) * | 2011-06-09 | 2016-07-05 | Xerox Corporation | Direct inkjet fabrication of drug delivery devices |
-
2014
- 2014-03-14 WO PCT/US2014/029168 patent/WO2014144661A1/en not_active Ceased
- 2014-03-14 HK HK16101295.2A patent/HK1213473A1/zh unknown
- 2014-03-14 EP EP14763925.6A patent/EP2968181B1/en active Active
- 2014-03-14 CN CN201480015723.7A patent/CN105050588B/zh active Active
- 2014-03-14 ES ES14763925T patent/ES2761407T3/es active Active
- 2014-03-14 MX MX2015012135A patent/MX365914B/es active IP Right Grant
- 2014-03-14 AU AU2014228861A patent/AU2014228861B2/en active Active
- 2014-03-14 CA CA2906172A patent/CA2906172C/en active Active
- 2014-03-14 JP JP2016503003A patent/JP6466399B2/ja active Active
-
2015
- 2015-08-27 US US14/837,354 patent/US9492380B2/en active Active
-
2016
- 2016-08-23 US US15/244,563 patent/US10420785B2/en active Active
-
2018
- 2018-08-22 AU AU2018220049A patent/AU2018220049B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016513724A5 (enExample) | ||
| ES2761407T3 (es) | Forma de dosificación rápidamente dispersable de topiramato | |
| JP6040218B2 (ja) | 口腔内崩壊錠用直打賦形剤及びその製造方法、並びに口腔内崩壊錠 | |
| JP2018162276A5 (enExample) | ||
| ES2244167T3 (es) | Nuevas preparaciones farmaceuticas multiunitarias estables que contienen bencimidazoles sustituidos. | |
| ES2320438T3 (es) | Formulacion farmaceutica oral de suspension acuosa de microcapsulas que permiten la liberacion modificada de principio(s) activo(s). | |
| JP2009512663A5 (enExample) | ||
| Kumar et al. | Impact of spray drying over conventional surface adsorption technique for improvement in micromeritic and biopharmaceutical characteristics of self-nanoemulsifying powder loaded with two lipophilic as well as gastrointestinal labile drugs | |
| JP2018517735A5 (enExample) | ||
| JP5761018B2 (ja) | 被覆固形製剤 | |
| JP2013540148A (ja) | 多粒子状の胃保持型製剤の製造方法 | |
| JP7681511B2 (ja) | インライン混合中の懸濁液の通気の最小化 | |
| JP2015533164A5 (enExample) | ||
| JP5160423B2 (ja) | 水易溶性薬物含有球状素顆粒の製造方法 | |
| CN108633256A (zh) | 含水胶囊、以及含水胶囊的制造方法 | |
| HK1209371A1 (en) | Oral and/or buccal composition in the form of a thin film of a weakly soluble active ingredient, method of preparing same and use of same | |
| Li et al. | Preparation and evaluation of nano-hydroxyapatite/poly (styrene-divinylbenzene) porous microsphere for aspirin carrier | |
| JP6042084B2 (ja) | 液状組成物、及びこれを含有する軟カプセル剤 | |
| JP6027911B2 (ja) | 賦形剤造粒物及びその製造方法、並びに錠剤 | |
| JP5454162B2 (ja) | フィルムコーティングされた昇華性成分含有固形製剤 | |
| JP2011046750A (ja) | 口腔内速崩壊性錠 | |
| US20040170686A1 (en) | Suspension vehicle for coated drug particles | |
| JP6815109B2 (ja) | デュロキセチンまたは薬学的に許容されるその塩を有効成分とする医薬組成物 | |
| CN102970980A (zh) | 控制释放的左乙拉西坦配方 | |
| JP6307874B2 (ja) | レイヤリング粒子 |